WHO ICTRP trial

A randomised controlled trial of oxytocin bolus versus oxytocin bolus and…

ISRCTN17813715 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting

Key facts

Trial ID ISRCTN17813715
Public title A randomised controlled trial of oxytocin bolus versus oxytocin bolus and infusion for the control of blood loss at elective caesarean section
Scientific title A multi-centre randomised controlled trial of oxytocin 5 IU bolus and placebo infusion versus oxytocin 5 IU bolus and 40 IU infusion for the control of blood loss at elective caesarean section
Primary sponsor Health Research Board of Ireland (Ireland)
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Specified
Countries Ireland
Conditions Study of blood loss at caesarean section associated with different use of oxytocin Signs and Symptoms Control of blood loss
Interventions Patients will be randomised in a double-blind trial to receive either: 1. An intravenous slow bolus of oxytocin (5 IU) and placebo infusion (500 ml 0.9% saline), or 2. An intravenous slow bolus of oxytocin (5 IU) and oxytocin infusion (40…
Registration date Mar 25, 2008
Target size 1500
Secondary IDs 2006-004799-11;EudraCT number 2006-004799-11
Registry page isrctn.com

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations